Going global – Travel and the 2019 novel coronavirus-Reference-Cited by-同舟云学术

Going global – Travel and the 2019 novel coronavirus

Published:2020-01 Issue: Volume:33 Page:101578
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

Rodríguez-Morales Alfonso J.,MacGregor Kirsten,Kanagarajah Sanch,Patel Dipti,Schlagenhauf Patricia

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference49 articles.

1. Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV);World Health Organization,2005-2020

2. Novel coronavirus (2019-nCoV) - situation report - 10 - 30 January 2020;World Health Organization,2020

3. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus;Rodriguez-Morales;Infez Med,2020

4. Modelling strategies for controlling SARS outbreaks;Gumel;Proc Biol Sci,2004

5. Risk factors for fatal Middle East respiratory syndrome coronavirus infections in Saudi Arabia: analysis of the WHO line list, 2013-2018;Rahman;Am J Publ Health,2019

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pandemic on Commuters’ Mode Choice Behavior: A Case Study of Dalian City, China;Transportation Research Record: Journal of the Transportation Research Board;2024-01-30

2. COVID-19 impacts on the water quality of aquatic environment in the Indian Ocean Rim region;Regional Studies in Marine Science;2023-12

3. Managing the COVID-19 pandemic in thirty-two policy measures in Saudi Arabia: A mixed-methods analysis;Journal of Infection and Public Health;2023-10

4. Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19;Journal of Molecular Structure;2023-09

5. A Multi-dimensional Review on Severe Acute Respiratory Syndrome Coronavirus-2;Current Pharmaceutical Biotechnology;2023-07